Asian-Pacific Consensus Guidelines recommend levofloxacin for H. pylori infection

The second Asia-Pacific Consensus Conference has reviewed the latest information on Helicobacter pylori management. The current recommended first-line treatment is a PPI-based triple therapy involving clarithromycin and metronidazole. However, in parts of Asia there is increasing resistance to both these drugs and a number of recommended salvage therapies have been proposed. One of these is levofloxacin-based triple therapy. 

J Gastroenterol Hepatol. 2009 Oct;24(10):1587-600.

Source : http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=
pubmed&dopt=Abstract&list_uids=19788600